117 related articles for article (PubMed ID: 1682948)
1. Attenuation of central alpha 2 adrenergic action in diabetic rats.
Guo TZ; Maze B; Maze M
Pharmacol Biochem Behav; 1991 Jun; 39(2):383-7. PubMed ID: 1682948
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic characterization of the receptor mediating the hypnotic action of dexmedetomidine.
Doze V; Chen BX; Li Z; Maze M
Acta Vet Scand Suppl; 1989; 85():61-4. PubMed ID: 2571279
[TBL] [Abstract][Full Text] [Related]
3. Role of pertussis toxin-sensitive G-proteins in the analgesic and anesthetic actions of alpha 2-adrenergic agonists in the rat.
Hayashi Y; Rabin BC; Guo TZ; Maze M
Anesthesiology; 1995 Oct; 83(4):816-22. PubMed ID: 7574062
[TBL] [Abstract][Full Text] [Related]
4. Pertussis toxin and 4-aminopyridine differentially affect the hypnotic-anesthetic action of dexmedetomidine and pentobarbital.
Doze VA; Chen BX; Tinklenberg JA; Segal IS; Maze M
Anesthesiology; 1990 Aug; 73(2):304-7. PubMed ID: 1974396
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine produces a hypnotic-anesthetic action in rats via activation of central alpha-2 adrenoceptors.
Doze VA; Chen BX; Maze M
Anesthesiology; 1989 Jul; 71(1):75-9. PubMed ID: 2568769
[TBL] [Abstract][Full Text] [Related]
6. Perturbation of ion channel conductance alters the hypnotic response to the alpha 2-adrenergic agonist dexmedetomidine in the locus coeruleus of the rat.
Nacif-Coelho C; Correa-Sales C; Chang LL; Maze M
Anesthesiology; 1994 Dec; 81(6):1527-34. PubMed ID: 7992922
[TBL] [Abstract][Full Text] [Related]
7. A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus in rats.
Correa-Sales C; Rabin BC; Maze M
Anesthesiology; 1992 Jun; 76(6):948-52. PubMed ID: 1350889
[TBL] [Abstract][Full Text] [Related]
8. Pertussis toxin-mediated ribosylation of G proteins blocks the hypnotic response to an alpha 2-agonist in the locus coeruleus of the rat.
Correa-Sales C; Reid K; Maze M
Pharmacol Biochem Behav; 1992 Nov; 43(3):723-7. PubMed ID: 1360160
[TBL] [Abstract][Full Text] [Related]
9. Central alpha 1-adrenoceptor stimulation functionally antagonizes the hypnotic response to dexmedetomidine, an alpha 2-adrenoceptor agonist.
Guo TZ; Tinklenberg J; Oliker R; Maze M
Anesthesiology; 1991 Aug; 75(2):252-6. PubMed ID: 1677547
[TBL] [Abstract][Full Text] [Related]
10. Chronic treatment with dexmedetomidine desensitizes alpha 2-adrenergic signal transduction.
Reid K; Hayashi Y; Hsu J; Maguire PA; Rabin BC; Guo TZ; Maze M
Pharmacol Biochem Behav; 1997; 57(1-2):63-71. PubMed ID: 9164555
[TBL] [Abstract][Full Text] [Related]
11. Hypnotic and analgesic effects of the alpha 2-adrenergic agonist dexmedetomidine in morphine-tolerant rats.
Hayashi Y; Guo TZ; Maze M
Anesth Analg; 1996 Sep; 83(3):606-10. PubMed ID: 8780290
[TBL] [Abstract][Full Text] [Related]
12. Desensitization to the behavioral effects of alpha 2-adrenergic agonists in rats.
Hayashi Y; Guo TZ; Maze M
Anesthesiology; 1995 Apr; 82(4):954-62. PubMed ID: 7717568
[TBL] [Abstract][Full Text] [Related]
13. Antisense technology reveals the alpha2A adrenoceptor to be the subtype mediating the hypnotic response to the highly selective agonist, dexmedetomidine, in the locus coeruleus of the rat.
Mizobe T; Maghsoudi K; Sitwala K; Tianzhi G; Ou J; Maze M
J Clin Invest; 1996 Sep; 98(5):1076-80. PubMed ID: 8787667
[TBL] [Abstract][Full Text] [Related]
14. Chronic administration of an alpha 2 adrenergic agonist desensitizes rats to the anesthetic effects of dexmedetomidine.
Reid K; Hayashi Y; Guo TZ; Correa-Sales C; Nacif-Coelho C; Maze M
Pharmacol Biochem Behav; 1994 Jan; 47(1):171-5. PubMed ID: 7906889
[TBL] [Abstract][Full Text] [Related]
15. Chronic desipramine treatment desensitizes the rat to anesthetic and antinociceptive effects of the alpha2-adrenergic agonist dexmedetomidine.
Guo TZ; Reid K; Davies MF; Nacif-Coelho C; Rabin BC; Gonzalez F; Maze M
Anesthesiology; 1998 Jun; 88(6):1634-42. PubMed ID: 9637658
[TBL] [Abstract][Full Text] [Related]
16. Central alpha 2-adrenoceptors are highly stereoselective for dexmedetomidine, the dextro enantiomer of medetomidine.
Savola JM; Virtanen R
Eur J Pharmacol; 1991 Mar; 195(2):193-9. PubMed ID: 1678707
[TBL] [Abstract][Full Text] [Related]
17. Functional effects of activation of alpha-1 adrenoceptors by dexmedetomidine: in vivo and in vitro studies.
Schwinn DA; Correa-Sales C; Page SO; Maze M
J Pharmacol Exp Ther; 1991 Dec; 259(3):1147-52. PubMed ID: 1684815
[TBL] [Abstract][Full Text] [Related]
18. Drugs acting at calcium channels can influence the hypnotic-anesthetic effect of dexmedetomidine.
Horváth G; Kovács M; Szikszay M; Benedek G
Acta Biochim Biophys Hung; 1991-1992; 26(1-4):75-81. PubMed ID: 1688240
[TBL] [Abstract][Full Text] [Related]
19. Sympatholytic and minimum anesthetic concentration-sparing responses are preserved in rats rendered tolerant to the hypnotic and analgesic action of dexmedetomidine, a selective alpha(2)-adrenergic agonist.
Rabin BC; Reid K; Guo TZ; Gustafsson E; Zhang C; Maze M
Anesthesiology; 1996 Sep; 85(3):565-73. PubMed ID: 8853087
[TBL] [Abstract][Full Text] [Related]
20. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects.
Nelson LE; Lu J; Guo T; Saper CB; Franks NP; Maze M
Anesthesiology; 2003 Feb; 98(2):428-36. PubMed ID: 12552203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
